STOCKHOLM, Feb. 5, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2024. Fourth Quarter 2024 Total revenue increased 9 per cent, 8 per cent at constant exchange rates, (CER)1, to SEK 7,436 M (6,844) Haematology revenue…
